Per the ASX announcement, the company will be presenting these initial srGVHD results at the forthcoming ISCT annual meeting:
Mesoblast has itself presented both COVID and heart results itself at former ISCT annual meetings and conferences.
Ann: Two-Year Results of Phase 1 SR-aGvHD Trial Presented at ISCT, page-57
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.5¢ |
Change
-0.010(4.26%) |
Mkt cap ! $40.41M | |||
| Open | High | Low | Value | Volume |
| 23.5¢ | 23.5¢ | 22.5¢ | $11.57K | 49.51K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 100000 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 7426 | 1 |
View Market Depth
| Last trade - 15.43pm 10/05/2024 (20 minute delay) ? |
|
|||||
|
Last
23.0¢ |
Change
-0.010 ( 0.00 %) |
||||
| Open | High | Low | Volume | ||
| 23.0¢ | 23.5¢ | 23.0¢ | 10710 | ||
| Last updated 15.01pm 10/05/2024 ? | |||||
| CYP (ASX) Chart |